AKCEA THERAPEUTICS, INC. Insider Trading for September 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AKCEA THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AKCEA THERAPEUTICS, INC. for September 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Option Exercise | M | 12.21 | 35,230 | 430,158 | 17,607 | |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Option Exercise | M | 12.21 | 35,230 | 430,158 | 17,607 | |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Option Exercise | M | 6.48 | 83,952 | 544,009 | 7,633 | |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Option Exercise | M | 6.48 | 83,952 | 544,009 | 7,633 | |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Option Exercise | M | 6.48 | 302,250 | 1,958,580 | 0 | |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Option Exercise | M | 6.48 | 302,250 | 1,958,580 | 0 | |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Payment of Exercise | F | 16.64 | 30,016 | 499,466 | 156,631 | 186.6 K to 156.6 K (-16.08 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Payment of Exercise | F | 16.64 | 30,016 | 499,466 | 156,631 | 186.6 K to 156.6 K (-16.08 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Buy | M | 12.21 | 35,230 | 430,158 | 186,647 | 151.4 K to 186.6 K (+23.27 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Buy | M | 12.21 | 35,230 | 430,158 | 186,647 | 151.4 K to 186.6 K (+23.27 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Payment of Exercise | F | 16.64 | 52,973 | 881,471 | 151,417 | 204.4 K to 151.4 K (-25.92 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Payment of Exercise | F | 16.64 | 52,973 | 881,471 | 151,417 | 204.4 K to 151.4 K (-25.92 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Buy | M | 6.48 | 83,952 | 544,009 | 204,390 | 120.4 K to 204.4 K (+69.71 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Buy | M | 6.48 | 83,952 | 544,009 | 204,390 | 120.4 K to 204.4 K (+69.71 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Payment of Exercise | F | 16.64 | 185,122 | 3,080,430 | 120,438 | 305.6 K to 120.4 K (-60.58 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Payment of Exercise | F | 16.64 | 185,122 | 3,080,430 | 120,438 | 305.6 K to 120.4 K (-60.58 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Buy | M | 6.48 | 302,250 | 1,958,580 | 305,560 | 3.3 K to 305.6 K (+9,131.42 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Goldberg Jeff Marc | Chief Operating Off ... | Buy | M | 6.48 | 302,250 | 1,958,580 | 305,560 | 3.3 K to 305.6 K (+9,131.42 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Option Exercise | M | 12.21 | 205,479 | 2,508,899 | 102,740 | |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Option Exercise | M | 6.48 | 145,303 | 941,563 | 13,209 | |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Option Exercise | M | 6.48 | 1,711,079 | 11,087,792 | 0 | |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Payment of Exercise | F | 16.64 | 175,064 | 2,913,065 | 678,149 | 853.2 K to 678.1 K (-20.52 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Buy | M | 12.21 | 205,479 | 2,508,899 | 853,213 | 647.7 K to 853.2 K (+31.72 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Payment of Exercise | F | 16.64 | 95,156 | 1,583,396 | 647,734 | 742.9 K to 647.7 K (-12.81 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Buy | M | 6.48 | 145,303 | 941,563 | 742,890 | 597.6 K to 742.9 K (+24.31 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Payment of Exercise | F | 16.64 | 1,113,492 | 18,528,507 | 597,587 | 1.7 M to 597.6 K (-65.08 %) |
| Sep 30 2019 | AKCA | AKCEA THERAPEUTICS ... | Soteropoulos Paula | Chief Executive Off ... | Buy | M | 6.48 | 1,711,079 | 11,087,792 | 1,711,079 | 0 to 1.7 M |
| Sep 23 2019 | AKCA | AKCEA THERAPEUTICS ... | O'Dea Louis | Chief Medical Offic ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
| Sep 23 2019 | AKCA | AKCEA THERAPEUTICS ... | MacLean Michael F | Chief Financial Off ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
| Sep 23 2019 | AKCA | AKCEA THERAPEUTICS ... | McDevitt Damien | Interim Chief Execu ... | Option Exercise | A | 22.46 | 400,000 | 8,984,000 | 400,000 | |
| Sep 23 2019 | AKCA | AKCEA THERAPEUTICS ... | McDevitt Damien | Interim Chief Execu ... | Grant | A | 0.00 | 200,000 | 0 | 200,000 | 0 to 200 K |
| Sep 23 2019 | AKCA | AKCEA THERAPEUTICS ... | YANG MICHAEL J. | Director | Option Exercise | A | 22.46 | 53,000 | 1,190,380 | 53,000 | |
| Sep 23 2019 | AKCA | AKCEA THERAPEUTICS ... | KLEIN JOSEPH III | Director | Option Exercise | A | 22.46 | 53,000 | 1,190,380 | 53,000 |